Published 2022-12-30
license
Artículos

Natural Killer Cells with Chimeric Antigen Receptor (CAR-NK): An Emerging Cancer Therapy

DOI: https://doi.org/10.22490/ECISA.9360
Olga Lucia Ostos Ortiz universidad nacional abierta y a distancia

Natural killer cells modified with chimeric antigen receptor (CAR-NK) have emerged as a promising therapeutic strategy in cancer immunotherapy. Unlike CAR-T cells, CAR-NK cells offer key advantages such as lower toxicity and the potential for allogeneic use without causing graft-versus-host disease. This paper analyzes the biological basis, clinical advances, and challenges in the application of this technology in oncology.

keywords: NK cells, immunotherapy, CAR-NK cells, cancer, cell therapy
license

How to Cite

Ostos Ortiz, O. L. (2022). Natural Killer Cells with Chimeric Antigen Receptor (CAR-NK): An Emerging Cancer Therapy: Una Terapia Emergente Contra el Cáncer. Documentos De Trabajo ECISA, 4. https://doi.org/10.22490/ECISA.9360
Metrics
Metrics Loading ...

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Design and implemented by